VRCI Verici Dx plc

0.2250GBp0.00%Mkt Cap: 5.59M $P/E: —

Verici Dx plc, together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States. The company develops Tutivia, a post-transp…

HeadlineSourceTime
Older
TradingView
directorstalkinterviews.com
KKalkine
Investing.com
Investing.com India
TradingView
TradingView
marketscreener.com
Kalkine Media
Kalkine Media
London South East
VVox Markets
Investing.com Nigeria
Investing.com
Investing.com UK
DirectorsTalk Interviews
tradingview.com
DirectorsTalk Interviews
directorstalkinterviews.com
Kalkine Media
TradingView
DirectorsTalk Interviews
SSmartkarma
DirectorsTalk Interviews
DirectorsTalk Interviews
marketscreener.com
Proactive financial news
VVox Markets
Proactive Investors
Yahoo Finance UK
DirectorsTalk Interviews
Kalkine Media
TThe National Law Review
TradingView
DirectorsTalk Interviews
DirectorsTalk Interviews
TradingView
TradingView
DirectorsTalk Interviews